Formation Venture Engineering β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample.
AI & Machine LearningBiotechMedical Devices
Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility.
BiotechHealthtechBeverly, US
Todd C. Zion(Executive Officer, Director)inJames Herriman(Executive Officer)Robyn Davis(Director)Lovick E. Cannon(Director)Thomas M. Lancaster(Executive Officer, Director)
Co-investorsBoston Harbor Angels
Reimagining hospital beds as diagnostic and therapeutic devices; sensor-cell technology monitors airflow, pressure, and skin health to prevent and heal bedsores.
LeviSense Medical is a Massachusetts-based medical device company developing next-generation technology for therapeutic beds used in wound care.
HardwareHealthtechMedical DevicesBeverly, US
Dave Bertoni(COO & Co-Founder)inShri Parikh(CEO & Director)inMichael McGarrity(Director)Peter Rock(Chief Financial Officer)inDonald Dye(Director)
BoardRahul Bhansali(Director)in
Co-investorsICV Venture Engineering
NeuroDex develops blood-based biomarkers and diagnostic assays for neurological diseases, including rare genetic disorders, Parkinson's disease, Alzheimer's disease, and ALS.
BiotechDigital HealthMedical DevicesArlington, US
Erez Eitan(Executive Officer, Director)inRaphael Nir(Director)Oded Biran(Executive Officer, Director)
Co-investorsICVICV Venture Engineering
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep TechHealthtechActon, US
Ruchi Chauhan(Director)
Co-investorsIllumina Accelerator
Builds scalable platforms for oligo synthesis and conjugation to support diagnostics and therapeutics.
BiotechEncinitas, US
Jimmy Hollis Williams(Executive Officer, Director)
Developing a precision immunotherapy approach to Alzheimer's, chronic pain, and neurodegenerative diseases; first graduate of FVE Foundry.
Twilight develops injectable precision immunotherapies to train the body's immune system to treat chronic diseases at scale.
BiotechDeep TechHealthtechMedical Devices
Ajay Verma(CEO, Co-Founder)Rahul Bhansali(CBO, Co-Founder)
Developer of Fc-fusion-based vaccines and boosters for infectious diseases, offering durable safety, broad-spectrum immunity, and room-temperature stability for global access.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.